Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TXGTXG
Showing 8 of 27 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in 10x Genomics Inc Class A

GEODE CAPITAL MANAGEMENT, LLC holds 3.1M shares of TXG (10x Genomics Inc Class A), worth $118.2M as of 2026-Q2. The position was increased (+6.2% shares). TXG represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$118.2M

Current Shares

3.1M

Total Value Change

+$77.2M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+6.2%
$118.2M0.0%$38.34
32
2026-Q1
Increased
2.9M
+4.1%
$61.7M0.0%$22.62
31
2025-Q4
Increased
2.8M
+2.9%
$45.5M0.0%$16.29
30
2025-Q3
Increased
2.7M
+2.3%
$31.7M0.0%$11.34
29
2025-Q2
Increased
2.7M
+41.2%
$30.7M0.0%$11.73
38
2025-Q1
Increased
1.9M
+3.5%
$16.4M0.0%$9.16
29
2024-Q4
Decreased
1.8M
-0.1%
$26.1M0.0%$14.35
0
2024-Q3
Increased
1.8M
+2.4%
$41M0.0%$22.67
30

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used